Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youfeng Yang

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Journal of Urology|October 23, 2012
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancerChristopher J Ricketts, Brian Shuch, Cathy D Vocke, et al.
Oncotarget|March 15, 2018
Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancersCarole Sourbier, Pei-Jyun Liao, Christopher J Ricketts, et al.
Cancer Cell|December 10, 2014
Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancerCarole Sourbier, Christopher J Ricketts, Shingo Matsumoto, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
Molecular Cancer Therapeutics|October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Journal of Urology|October 23, 2012
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancerChristopher J Ricketts, Brian Shuch, Cathy D Vocke, et al.
Oncotarget|March 15, 2018
Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancersCarole Sourbier, Pei-Jyun Liao, Christopher J Ricketts, et al.
Cancer Cell|December 10, 2014
Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancerCarole Sourbier, Christopher J Ricketts, Shingo Matsumoto, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
Molecular Cancer Therapeutics|October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Pageof 7